Date: 2014-10-09
Type of information: Nomination
Compound:
Company: Transgene (France)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On October 9, 2014, Transgene announced the further strengthening of its management team following the recent arrival of Eric Quémeneur as Executive Vice President, Vice President Research & Development. The management committee of Transgene, chaired by Philippe Archinard, Chairman and Chief Executive Officer, is now composed of: Eric Quémeneur; Dr Nathalie Adda, Vice President, Chief Medical Officer; Christophe Ancel, Vice President Quality and Qualified Person; Jean-Philippe Del, Vice President Finance; Thibaut du Fayet, Vice President Alliance Management, Project Management and Marketing; Colin Freund, Vice President Business Development; Patrick Mahieux, Vice President Industrial and Pharmaceutical Operations; and Hemanshu Shah, Vice President Medical Affairs.
- Stéphane Boissel, Executive Vice President and Chief Financial Officer, announced that he is leaving the Company to pursue other opportunities.
Financial terms:
Latest news:
Is general: Yes
